We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$4.11M
2
POOL icon
Pool Corp
POOL
+$4M
3
EL icon
Estee Lauder
EL
+$3.62M
4
CRM icon
Salesforce
CRM
+$2.95M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$2.51M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.48M
2
DHI icon
D.R. Horton
DHI
+$4.76M
3
CSCO icon
Cisco
CSCO
+$4.46M
4
STZ icon
Constellation Brands
STZ
+$4.2M
5
DGX icon
Quest Diagnostics
DGX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 21.18%
2 Healthcare 10.11%
3 Financials 8.69%
4 Consumer Discretionary 6.97%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
76
Monster Beverage
MNST
$93.2B
$2.7M 0.29%
47,029
-2,174
-4% -$124K
WM icon
77
Waste Management
WM
$95.5B
$2.69M 0.28%
15,510
+188
+1% +$31.1K
GOOG icon
78
Alphabet (Google) Class C
GOOG
$3.99T
$2.67M 0.28%
22,105
+393
+2% +$45.5K
EQIX icon
79
Equinix
EQIX
$103B
$2.57M 0.27%
3,275
-1,047
-24% -$766K
VEEV icon
80
Veeva Systems
VEEV
$31.6B
$2.51M 0.27%
12,698
+3,255
+34% +$594K
UNP icon
81
Union Pacific
UNP
$178B
$2.48M 0.26%
12,127
-2,931
-19% -$583K
MRSH
82
Marsh
MRSH
$87.5B
$2.42M 0.26%
12,853
-3,206
-20% -$569K
LW icon
83
Lamb Weston
LW
$7.3B
$2.4M 0.25%
20,880
+4,146
+25% +$462K
CMCSA icon
84
Comcast
CMCSA
$80.9B
$2.36M 0.25%
56,887
-20,142
-26% -$800K
IVV icon
85
iShares Core S&P 500 ETF
IVV
$869B
$2.34M 0.25%
5,240
-1,084
-17% -$457K
BRK.B icon
86
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.26M 0.24%
6,639
-135
-2% -$44.1K
VUG icon
87
Vanguard Growth ETF
VUG
$216B
$2.23M 0.24%
47,328
-882
-2% -$38.2K
PFE icon
88
Pfizer
PFE
$141B
$2.2M 0.23%
60,037
+697
+1% +$27.1K
MA icon
89
Mastercard
MA
$487B
$2.2M 0.23%
5,586
-23
-0.4% -$8.63K
ZBRA icon
90
Zebra Technologies
ZBRA
$12.6B
$2.1M 0.22%
7,108
+1,151
+19% +$323K
VGSH icon
91
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$2.08M 0.22%
36,099
-2,244
-6% -$131K
MTCH icon
92
Match Group
MTCH
$9.05B
$2.07M 0.22%
49,437
+17,256
+54% +$631K
SNPS icon
93
Synopsys
SNPS
$74.5B
$2.06M 0.22%
4,722
+556
+13% +$224K
BMY icon
94
Bristol-Myers Squibb
BMY
$128B
$2.04M 0.22%
31,949
+3,253
+11% +$218K
BX icon
95
Blackstone
BX
$106B
$2.03M 0.21%
21,791
+6,567
+43% +$567K
STZ icon
96
Constellation Brands
STZ
$22.2B
$2.01M 0.21%
8,171
-17,962
-69% -$4.2M
ADI icon
97
Analog Devices
ADI
$181B
$1.97M 0.21%
10,111
+828
+9% +$153K
BNDX icon
98
Vanguard Total International Bond ETF
BNDX
$82.2B
$1.97M 0.21%
40,223
-2,735
-6% -$133K
LOW icon
99
Lowe's Companies
LOW
$119B
$1.96M 0.21%
8,671
-153
-2% -$31.8K
APTV icon
100
Aptiv
APTV
$12.2B
$1.87M 0.2%
18,303
+2,401
+15% +$237K
2 3
4
5 6

Similar funds

PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return

Girard Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
  • Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
  • Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
  • Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
  • Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
  • Girard Partners opened 13 new positions and closed 13 in Q2 2023.
  • Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.

Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.